Article
Integrative analysis of genomic alteration, immune cells infiltration and prognosis of lung squamous cell carcinoma (LUSC) to identify smoking-related biomarkers.
International immunopharmacology - 1 Dec 2020
Li Jia, Li Huahua, Zhang Chenyue, Zhang Chenxing, Wang Haiyong
Abstract excerpt
Lung squamous cell carcinoma (LUSC) is the most common histologic type of smoking-related non-small cell lung cancer (NSCLC). However, there are no identified potential biomarkers for smoking-related LUSC diagnosis and prognosis. Especially, the characteristics of genetic alteration and tumor microenvironment induced by cigarette smoking remain unknown. Here, we performed integrative analysis of 463 LUSC with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
